Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE

Paris, France
10 Sep 2016 - 12 Sep 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Free Communications

Bone & Mineral Metabolism

Characterization of GNAS miRNAs Targets: Trying to Better Understand the Pathophysiology of Pseudohypoparathyroidism 1B (PHP1B)
aINSERM Bicêtre Paris Sud, Bicêtre Paris Sud, France; bMD, PhD, INSERM and APHP, Trousseau, Paris, France; cINSERM Bicêtre Paris Sud, Bicêtre Paris Sud, France; dMD, PhD, INSERM and APHP, CMR Calcium-Phosphore, Bicêtre Paris Sud, France
hrp0086fc2.1
From Pseudohypoparathyroidism to Inactivating PTH/PTHrP Signaling Disorder (iPPSD), a Novel Classification Proposed by the European EuroPHP-Network
aDivision of Experimental Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Lübeck, Luebeck, Germany; bFondazione IRCCS Ca’ Granda Ospedal Maggiore Policlinico, Endocrinology and Diabetology Unit, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy; cAPHM, Hôpital la Conception, Laboratory of Molecular Biology, Marseille, France; dDepartment of Cardiovascular Sciences, Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium; eMolecular (Epi)Genetics Laboratory, BioAraba National Health Institute, Hospital Universitario Araba-Txagorritxu, Vitoria-Gasteiz, Spain; fAPHP, Reference center for rare disorders of the mineral metabolism and Plateforme d’Expertise Maladies Rares Paris-Sud, Le Kremlin Bicêtre, 94270, Paris, France; gINSERM U1169, Hôpital Bicêtre, Le Kremlin Bicêtre, et Université Paris-Saclay, Paris, France; hDepartment of Endocrinology and Nutrition, La Paz University Hospital, Madrid, Spain; iDepartment of Public Health and Pediatric Sciences, University of Torino, Torino, Italy; jService de Biochimie et Génétique Moléculaires, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France; kDepartment of Pediatrics, Division of Endocrinology and Diabetes, Marmara University, Istanbul, Turkey; lDepartment of Endocrinology and Diabetes, Birmingham Children’s Hospital, Birmingham, UK
hrp0086fc2.2
The Impact of Intragastric Balloon Placement Suppported by a Lifestyle Intervention Programme on Cortical and Trabecular Microstructure and Strength in Severely Obese Adolescents
aUniversity of Sheffield, Sheffield, UK; bSheffield Children’s Hospital, Sheffield, UK; cSheffield Hallam University, Sheffield, UK
hrp0086fc2.3
Effect of KRN23, a Fully Human Anti-FGF23 Monoclonal Antibody, on Rickets in Children with X-linked Hypophosphatemia (XLH): 40-week Interim Results from a Randomized, Open-label Phase 2 Study
aAPHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; bYale University School of Medicine, New Haven, Connecticut, USA; cIndiana University School of Medicine, Indianapolis, Indiana, USA; dUniversity of Groningen, Groningen, The Netherlands; eBirmingham Children’s Hospital, Birmingham, UK; fRoyal Manchester Children’s Hospital, Manchester, UK; gGreat Ormond Street Hospital, London, UK; hShriners Hospital for Children, St. Louis, Missouri, USA; iUltragenyx Pharmaceutical Inc., Novato, California, USA; jUniversity of California, San Francisco, California, USA
hrp0086fc2.6